Key result
Blockade of calcium-activated potassium channels with TEA had no independent effect on active vasodilation (63.2% vs 57.4% CVC, P=0.27), but interacted with NOS inhibition.
Why the study?
Does blockade of calcium-activated potassium channels, nitric oxide synthase, and inward rectifier/ATP-sensitive potassium channels alter cutaneous active vasodilation during passive heating in humans?
Does blockade of calcium-activated potassium channels, nitric oxide synthase, and inward rectifier/ATP-sensitive potassium channels alter cutaneous active vasodilation during passive heating in humans?
There is a complex interplay between vasodilatory pathways in human cutaneous microvasculature, with cross-talk between nitric oxide, calcium-activated potassium channels, and inward rectifier/ATP-sensitive potassium channels during active vasodilation.
EDHFs contribute to active vasodilation during heating; hypothesis-generating for thermoregulatory mechanisms and leaves open clinical translation.
In human cutaneous microvasculature, endothelium-derived hyperpolarizing factors (EDHFs) account for a large portion of vasodilation associated with local stimuli. Thus we sought to determine the role of EDHFs in active vasodilation (AVD) to passive heating in two protocols. Whole body heating was achieved using water-perfused suits (core temperature increase of 0.8-1.0°C), and skin blood flow was measured using laser-Doppler flowmetry. In the first protocol, four sites were perfused continuously via microdialysis with: 1) control; 2) tetraethylammonium (TEA) to block calcium-activated potassium (KCa) channels, and thus the actions of EDHFs; 3) N-nitro-l-arginine methyl ester (l-NAME) to inhibit nitric oxide synthase (NOS); and 4) TEA + l-NAME (n = 8). Data are presented as percent maximal cutaneous vascular conductance (CVC). TEA had no effect on AVD (CVC during heated plateau: control 57.4 ± 4.9% vs. TEA 63.2 ± 5.2%, P = 0.27), indicating EDHFs are not obligatory. l-NAME attenuated plateau CVC to 33.7 ± 5.4% (P < 0.01 vs. control); while TEA + l-NAME augmented plateau CVC compared with l-NAME alone (49.7 ± 5.3%, P = 0.02). From these data, it appears combined blockade of EDHFs and NOS necessitates dilation through other means, possibly through inward rectifier (KIR) and/or ATP-sensitive (KATP) potassium channels. To test this second hypothesis, we measured AVD at the following sites (n = 8): 1) control, 2) l-NAME, 3) l-NAME + TEA, and 4) l-NAME + TEA + barium chloride (BaCl2; KIR and KATP blocker). The addition of BaCl2 to l-NAME + TEA reduced plateau CVC to 32.7 ± 6.6% (P = 0.02 vs. l-NAME + TEA), which did not differ from the l-NAME site. These data combined demonstrate a complex interplay between vasodilatory pathways, with cross-talk between NO, KCa channels, and KIR and/or KATP channels.
No takes yet. Share an insight, caveat, or question.
Brunt et al. (2013) studied Cutaneous active vasodilation (n=8). Tetraethylammonium (TEA) vs. Control was evaluated on Percent maximal cutaneous vascular conductance (CVC) during heated plateau (p=0.27). Blockade of calcium-activated potassium channels with TEA had no independent effect on active vasodilation (63.2% vs 57.4% CVC, P=0.27), but interacted with NOS inhibition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: